Prevalence of altering selected spirometry maneuvers in asthma clinical trials.

C. Mottram (Rochester, United States of America), G. Sowman (Buckingham, United Kingdom)

Source: Virtual Congress 2021 – Future advances in respiratory physiology
Session: Future advances in respiratory physiology
Session type: E-poster
Number: 2514

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Mottram (Rochester, United States of America), G. Sowman (Buckingham, United Kingdom). Prevalence of altering selected spirometry maneuvers in asthma clinical trials.. 2514

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ArtiQ.QC facilitates spirometry quality control in asthma and COPD clinical trials
Source: Virtual Congress 2021 – Future advances in respiratory physiology
Year: 2021


A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019
Year: 2019



Measuring bronchodilation in COPD clinical trials
Source: Eur Respir J 2004; 24: Suppl. 48, 122s
Year: 2004

Comparative assessment of the qol specific parameters in children with bronchial asthma with standard pharmacotherapy, and in additional course of physiotherapy in the pool
Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects
Year: 2018

The usefulness of the impulse oscillometry for predicting the treatment outcomes of bronchial thermoplasty in patients with severe asthma.
Source: International Congress 2018 – Asthma analysis
Year: 2018




Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Variability and lack of predictive ability of asthma end-points in clinical trials
Source: Eur Respir J 2002; 20: 1102-1109
Year: 2002



Usefulness of portable spirometry in addition to clinical asthma control score (C-ACT) in atopic children before performing an oral food challenge.
Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure
Year: 2018


Does measuring pre or post bronchodilator FEV1 influence the level of asthma control in patients with controlled or partially controlled asthma as measured by GINA scale?
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013


Physiological responses during four clinical exercise protocols in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 286s
Year: 2002

Clinical use of induced sputum in the management of asthma. A noninvasive measurements of airway
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy?
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
Year: 2006

FeNO is not affected by spirometry, IOS or walking in healthy subjects or well controlled asthma patients
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020

Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013


Are spirometric criteria good predictors of longitudinal outcomes in COPD patients without taking chronic respiratory symptoms into account? Results from ECRHS
Source: Annual Congress 2008 - Environmental risk factors for respiratory symptoms and COPD
Year: 2008

Characteristics of clinical and objective measures of asthma control in asthmatic children
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Physiological responses during different clinical exercise protocols in COPD patients
Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment
Year: 2009

Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial
Source: Eur Respir J 2007; 30: 457-466
Year: 2007